Stockreport

Intellia Therapeutics Pops on CRISPR Trial Success. Does That Make NTLA Stock a Buy? [Yahoo! Finance]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF This milestone represents the first-ever global Phase 3 data for an in vivo CRISPR therapy, proving the technology is clinically viable. Intellia Therapeutics stock ha [Read more]